# The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-efficacy-of-switching-from-etanercept-to-infliximab-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Karen E. Hansen,Julie P Hildebrand,Mark C. Genovese,John J. Cush,S. R. Patel,David A. Cooley,Stanley Cohen,Ronald E. Gangnon,Michael Schiff |
| Citations | 118 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2413043776 |
| PMID | 15170921 |
| Type | article |
| Year | 2004 |

## Paper authors

- [Karen E. Hansen](https://scholariq.org/researchers/karen-e-hansen/)

## Paper journal

- [PubMed](https://scholariq.org/journals/pubmed/)

## Paper primary topic

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Paper topics

- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
